Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Myoglobin does not predict local toxicity in isolated limb perfusion

Artikel i vetenskaplig tidskrift
Författare Andreas Wendt Nyström
Jan Mattsson
Roger Olofsson Bagge
Publicerad i International Journal of Hyperthermia
Volym 33
Nummer/häfte 6
Sidor 679-683
ISSN 0265-6736
Publiceringsår 2017
Publicerad vid Institutionen för kliniska vetenskaper, sektionen för kirurgi och kirurgisk gastroforskning, Avdelningen för kirurgi
Sidor 679-683
Språk English
Länkar 10.1080/02656736.2017.1309082
Ämnesord Isolated limb perfusion, ILP, local toxicity, Wieberdink, myoglobin, melanoma, rhabdomyolysis, chemotherapy, injury, serum, en iw, 1980, clinical chemistry, v26, p1864
Ämneskategorier Radiologi och bildbehandling, Cancer och onkologi

Sammanfattning

Introduction: Isolated limb perfusion (ILP) is a treatment option for patients with in-transit metastases of malignant melanoma in the extremities, as well as locally advanced sarcoma. ILP allows for a delivery of high-dose chemotherapy to an isolated extremity with minimal systemic toxicity. However, local toxicity like oedema, blistering, nerve damage and compartment syndrome can occur. Myoglobin measurements have been used as a screening method to predict the most severe cases of local toxicity. The aim was to investigate if myoglobin is a predictive factor for local toxicity after ILP in patients with melanoma in-transit metastases. Methods: One hundred and ninety-three patients were treated for the first time with ILP for in-transit metastases between 2001 and 2015. Myoglobin was measured once the first hours after the perfusion (POD0), and for the first five post-operative days (POD1-5). Local toxicity was graded according to Wieberdink, and grouped in mild (I and II), moderate (III), and severe (IV and V). Wieberdink-groups were compared with myoglobin measurements, and myoglobin measurements were compared between gender, perfusion time, perfusion temperature and cannulated vessels. Results: There is no statistically significant difference in myoglobin serum levels during the first five days post perfusion between patients suffering from mild, moderate or severe local toxicity. There is no difference between toxicity groups when it comes to distribution of sex, tumour size, or tumour numbers. Conclusion: Levels of myoglobin do not predict local toxicity for patients with melanoma in-transit metastases treated with ILP when measured during the first five post-operative days.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?